Aoxin

CATALIST-listed AOXIN Q&M records 21% growth in revenue for full year ended 31 December 2021

Retrieved on: 
Wednesday, February 23, 2022
People, Acumen, PCR, Government, Raffles, Social Security, Ministry, COVID-19, Company, Collyer Quay, Dentist, UOB-Kay Hian, Research, Infection, City, Growth, Public expenditure, Sponsor, Percussion section, List of health departments and ministries, Sale, Environment, Consultant, Catalist, Vaccination, SGX, Efficiency, ART, NASDAQ, Polymerase chain reaction, Aoxin, Gemini, Sepsis, Patient, Exchange, Omicron, The Gemini, COVID-19 testing, Industry, Republic, Acquisition, Cancer, Income, Hospital, Health insurance, Pharmaceutical industry, Animal, Healthcare, Vaccine, Medical device, Dentistry, PRC, Group, Health, EBITDA

SINGAPORE, Feb 23, 2022 - (ACN Newswire) - Catalist listed Aoxin Q&M Dental Limited ("Aoxin" or "the Group"), today announced a 20.8% increase in revenue to RMB160.2 million for full year ended 31 December 2021 ("FY2021").

Key Points: 
  • SINGAPORE, Feb 23, 2022 - (ACN Newswire) - Catalist listed Aoxin Q&M Dental Limited ("Aoxin" or "the Group"), today announced a 20.8% increase in revenue to RMB160.2 million for full year ended 31 December 2021 ("FY2021").
  • However, Aoxin Q&M's dental services make it resilient and well-positioned ride out the current downturn to capitalize on strategic opportunities in the post-COVID healthcare sector".
  • We are keeping a close watch on the evolving COVID-19 situation in PRC, while managing our costs with strict discipline."
  • Revenue from primary healthcare segment increased by 19.7% from RMB78.5 million in FY2020 to RMB93.9 million in FY2021.

Q&M Dental records historic highest-ever revenue and profit after tax for year ended 31 December 2021 and declares a full year dividend yielding 7%

Retrieved on: 
Wednesday, February 23, 2022
People, Acumen, See, PCR, COVID-19, Ministry, Company, Motherboard, Dentist, Bank, UOB-Kay Hian, Research, Bloodstream infections, Growth, The Group, Percussion section, List of health departments and ministries, Sale, Singapore Exchange, Catalist, Exercise, MOH, ART, Group, NASDAQ, Polymerase chain reaction, Aoxin, Gemini, Sepsis, Patient, Pneumonia, Omicron, The Gemini, COVID-19 testing, Artificial intelligence, Industry, PDF, Republic, Acquisition, ASEAN, Infection, Cancer, EBITDA, Hospital, Holding company, Health insurance, Pharmaceutical industry, Medical device, Dentistry, Vaccine, Animal, Tutoring, PRC, Health

Revenue from medical laboratory and dental equipment & supplies segment jumped by 304% to S$45.4 million.

Key Points: 
  • Revenue from medical laboratory and dental equipment & supplies segment jumped by 304% to S$45.4 million.
  • The Group's net profit after tax in FY2021 increased by 98% to S$39.4 million from the S$19.8 million recorded in FY2020.
  • PATMI (Profit after tax attributable to Shareholders excluding Minorities) grew by 55% to S$30.5 million, from S$19.7 million in the previous period.
  • As at 31 December 2021, the Group has 136 dental clinics as compared to 118 in 31 December 2020, an increase of 18.

Q&M Dental net profit surges 154% to S$35.4M for nine months ended 30 September 2021

Retrieved on: 
Thursday, November 11, 2021
Acumen, People, COVID-19, ART, Acquisition, Cancer, Industry, Artificial intelligence, Aoxin, PCR, Infection, Philosophy, Growth, Investment, Associate company, Research, Sepsis, EBITDA, Dentist, Sale, Percussion section, Bank, COVID-19 testing, Catalist, Hospital, Company, Unity, IMM, The Group, Singapore Exchange, ASEAN, Motherboard, Bedok Reservoir, Patient, Group, Republic, Holding company, Vaccine, Health insurance, Pharmaceutical industry, Medical device, Dentistry

The Group's net profit after tax increased by 154% to S$35.4 million from S$13.9 million in the previous period.

Key Points: 
  • The Group's net profit after tax increased by 154% to S$35.4 million from S$13.9 million in the previous period.
  • The Group's net profit after tax increased by 175% to S$13.9 million, from S$5.1 million in the previous period.
  • As at 30 September 2021, the Group's number of dental clinics in Singapore has grown to 90, from 81 as at 30 September 2020.
  • Q&M Dental Group (Singapore) Limited ("Q&M" or together with its subsidiaries, the "Group") is a leading private dental healthcare group in Asia.